Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$307.80 USD

307.80
3,427,831

+6.66 (2.21%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $307.00 -0.80 (-0.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (175 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

The Zacks Analyst Blog Highlights: McDonald's, 3M, Stryker, Goldman Sachs and Kinder Morgan

by Zacks Equity Research

The Zacks Analyst Blog Highlights: McDonald???s, 3M, Stryker, Goldman Sachs and Kinder Morgan

    Zacks Equity Research

    Top Stock Reports for McDonald's, 3M & Stryker

    by Zacks Equity Research

    Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), 3M (MMM), and Stryker (SYK).

      Zacks Equity Research

      Med-Products' Q2 Earnings Roster for Jul 27: ALGN, BSX & More

      by Zacks Equity Research

      The ongoing conflict related to healthcare policy implementation in the U.S. might get reflected in the Q2 results of these companies.

        Zacks Equity Research

        Why Earnings Season Could Be Great for Stryker Corporation (SYK)

        by Zacks Equity Research

        Stryker Corporation (SYK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.

          Zacks Equity Research

          Ecolab (ECL) to Report Q2 Earnings: Will It Pull a Surprise?

          by Zacks Equity Research

          Despite an upbeat guidance, cutthroat competition in the niche space is likely to mar Ecolab's (ECL) growth in the second quarter.

            Zacks Equity Research

            Can Henry Schein (HSIC) Spring a Surprise in Q2 Earnings?

            by Zacks Equity Research

            The timing of Good Friday is likely to dampen sales at Henry Schein (HSIC) in second-quarter 2017. Meanwhile, geographic expansion should continue.

              Zacks Equity Research

              Can Cerner (CERN) Deliver a Beat this Earnings Season?

              by Zacks Equity Research

              We believe Cerner's (CERN) strong sales performance, solid portfolio and strategic initiatives have positioned it for stellar growth.

                Zacks Equity Research

                Can Illumina (ILMN) Spring a Surprise this Earnings Season?

                by Zacks Equity Research

                Illumina (ILMN) is well poised to witness steady top-line growth in Q2. Yet, the bottom line may remain stressed.

                  Zacks Equity Research

                  Will Stryker (SYK) Deliver a Beat this Earnings Season?

                  by Zacks Equity Research

                  The growing adoption of Stryker's (SYK) MAKO robots is expected to drive second-quarter 2017 sales in the orthopedic and reconstructive surgery market.

                    Zacks Equity Research

                    Is a Surprise in Store for ResMed (RMD) in Q4 Earnings?

                    by Zacks Equity Research

                    Currency headwind is likely to dampen ResMed's (RMD) gains in the COPD and sleep apnea market.